Lilly Plans to Build USD 6.5 Billion Facility to Manufacture APIs in Texas
Eli Lilly will invest USD 6.5 billion to set up a new API manufacturing facility in Houston, Texas—its eighth US site since 2020—creating over 4,600 jobs and boosting domestic production of small molecule medicines.
Manufacturing | 24/09/2025 | By Dineshwori | 363
Pharma Pro & Pack Expo 2025: CN Water Unveils AQU@Sense and Remote Monitoring Platform
India’s leading high-purity water solutions company, CN Water, concluded a successful showcase at the Pharma Pro & Pack Expo 2025 in India, highlighting two of its industry-leading solutions - AQU@Sense and CNtinel Remote Monitoring platform - which are redefining water operations for pharmaceutical manufacturing.
Manufacturing | 22/09/2025 | By Dineshwori | 252
FDA Introduces Pilot Scheme to Simplify Nicotine Pouch Manufacturers' Research Obligations
The U.S. Food and Drug Administration (FDA) is set to ease research requirements for manufacturers of nicotine pouches under a new pilot scheme, according to internal meeting transcripts. This marks the clearest indication yet of a more relaxed approach to smoking alternatives.
Manufacturing | 22/09/2025 | By Darshana | 305
Lupin's Nagpur Injectable Facility Receives Six Observations in USFDA Inspection
Lupin’s injectable facility in Nagpur has received six observations from the US Food and Drug Administration (USFDA), following an inspection conducted between the 8th and 16th of September 2025.
Manufacturing | 19/09/2025 | By Darshana | 470
Enzene, Aurobindo and Biocon Boost US Manufacturing with Major New Jersey Expansions
This month, three leading Indian firms — Enzene Biosciences, Aurobindo Pharma, and Biocon — have inaugurated major facilities in New Jersey, underscoring a growing trend of onshore investment by Indian pharma companies.
Manufacturing | 18/09/2025 | By Dineshwori | 472
GSK to Invest USD 30 Billion in US R&D and Supply Chain Over Next 5 Years
GSK has announced plans to invest USD 30 billion across the United States over the next five years to strengthen its R&D, drug discovery, development, and clinical trial activity.
Manufacturing | 17/09/2025 | By Dineshwori | 326
Piramal Pharma Solutions, the CDMO arm of Piramal Pharma Ltd., has installed a state-of-the-art Korsch XM-12 bilayer tablet press at its Morpeth, UK facility to enhance precision, efficiency, and flexibility in oral solid manufacturing.
Manufacturing | 16/09/2025 | By Mrinmoy Dey | 235
The partnership aims to speed up market entry for biopharma firms by combining Mycenax's biologics expertise with Spera Pharma’s high-potent fill-finish capabilities, offering an integrated, cost-effective ADC development platform.
Manufacturing | 15/09/2025 | By Dineshwori | 279
Aenova Expands Microbiology QC Lab at Latina Site to Boost Sterile Manufacturing
Aenova has announced a major expansion of its microbiology quality control (QC) laboratory at its Latina site in Italy to attract new customers seeking expertise in sterile manufacturing.
Manufacturing | 13/09/2025 | By Dineshwori | 447
New GST Rates: DCGI Orders Medical Device Makers to Update MRP Within 3 Months
The Central Drugs Standard Control Organization (CDSCO) has directed manufacturers and importers of Class C and D medical devices to update their inventories with revised MRP reflecting the newly reduced 5 percent Goods and Services Tax (GST).
Manufacturing | 12/09/2025 | By Dineshwori | 713
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy